XIV Eurasian Hematology-Oncology Congress - EHOC 2023

 

XIV Eurasian Hematology-Oncology Congress - EHOC 2023
M

Case Discussion: Ven+Aza Maintanance After Intensive Induction in 33 y/o Intermediate-Risk AML Patient

By XIV Eurasian Hematology-Oncology Congress - EHOC 2023 FEATURING Mehmet Yilmaz
By XIV Eurasian Hematology-Oncology Congress - EHOC 2023 FEATURING Mehmet Yilmaz
11 views
February 15, 2024
Comments 0
Login to view comments. Click here to Login
Leukemia
17:15

Clinical Case of BPDCN

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

H. Hamed

25 views
19:51

A 50-Year Personal Perspective on the Treatment of AML

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

C. Schiffer

163 views
12:11

Induction Therapy Choices and Responses of ALL in a Third World Coun…

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

A. Zafar

16 views
14:43

Is HSCT Necessary to Consolidate Hematological Remission After CAR-T…

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

F. Saglio

43 views
07:25

BK Virus Infections in Pediatric Leukemia During Treatment

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

D. KaçAr

15 views
08:11

Molecular Characteristics and Treatment Response to COG-ALL Protocol…

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

B. GüNer Yılmaz

8 views
13:09

Inaticabtagene Autoleucel Treatment in Adult R/R B-Cell ALL in China

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

L. Lulu

7 views
16:52

CLL: Future Perspectives and Unanswered Questions

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

A. Ferrajoli

216 views
15:36

Debates in CLL: The Case for Combination Therapy in 1L

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

A. Ibrahim

23 views
12:23

Debates in CLL: The Case for BTKi Monotherapy in 1L

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

G. Musuraca

55 views
06:14

CLL Case Presentation: 72 y/o Male With Cardiac Comorbidities

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

F. Eda Nuhoğlu Kantarcı

13 views
08:11

State-of-the-Art in CLL Treatment

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

A. Cuneo

504 views
08:54

Future Perspectives in CML

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

N. Chaudhri

17 views
07:46

Debates in CML: Imatinib is NOT the Best Choice for 1L TKI

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

T. Sacha

12 views
13:06

Debates in CML: Imatinib is the Best Choice for 1L TKI

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

G. Saglio

9 views
14:31

CML Case Presentation: A Patient With Multiple TKI Failure

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

D. Özmen İbiş

11 views
12:22

CML Case Presentation: A Young Patient With TKI Intolerance and Resi…

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

C. Fava

12 views
14:44

CML: State-of-the-Art and Progress Towards Cure

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

P. Raanani

14 views
20:06

Current and Future Approaches to the Treatment of B- and T-ALL

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

D. Hoelzer

31 views
18:14

Acute Promyelocytic Leukemia: Risk Stratification and New Treatment …

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

S. ÇAkı Kılıç

80 views
16:07

Pediatric AML: Diagnosis and Risk Stratification

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

N. Karadaş

178 views
26:45

Therapeutic Challenges and BMT in Pediatric Patients With CML

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

T. Ileri

9 views
26:32

Pediatric CML Treatment Options and Management

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

O. TüFekçI GüRocak

15 views
08:29

Effect of GVHD Prophylaxis on the Leukemia-Free Survival in Pediatri…

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

O. Aylin Boran

20 views
15:56

Pediatric CML Diagnosis

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

A. Meral Güneş

11 views
08:34

Adults With ALL: When Not to Transplant

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

E. Jabbour

36 views
13:19

Adults With ALL: When to Transplant

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

S. Chiaretti

19 views
08:39

Feasibilty of Therapy for Elderly Ph+ ALL Patients

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

G. Marconi

23 views
15:43

Recent Updates in ALL Treatment

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

G. Martinelli

21 views
14:12

Future Directions in AML: Optimizing Doublets and Triplets to Improv…

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

N. Daver

57 views
05:14

Case Discussion: Ven+Aza Maintanance After Intensive Induction in 33…

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

M. Yilmaz

11 views
11:17

State of the Art: Role of Maintenance Therapy in AML

XIV Eurasian Hematology-Oncology Congress - EHOC 2023

Z. Aziz

230 views